Ground-breaking trial brings personalised treatments to those with rare cancers
23 Aug 2017
Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.
Read More